Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
87.3M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
1.86M
-
Shares change
-
-241K
-
Total reported value, excl. options
-
$9.33M
-
Value change
-
-$1.2M
-
Put/Call ratio
-
2.84
-
Number of buys
-
8
-
Number of sells
-
-9
-
Price
-
$4.99
Significant Holders of Immunome Inc. - COMMON STOCK (IMNM) as of Q1 2023
35 filings reported holding IMNM - Immunome Inc. - COMMON STOCK as of Q1 2023.
Immunome Inc. - COMMON STOCK (IMNM) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.86M shares
of 87.3M outstanding shares and own 2.13% of the company stock.
Largest 10 shareholders include Prentice Capital Management, LP (432K shares), VANGUARD GROUP INC (374K shares), Alpine Global Management, LLC (366K shares), MILLENNIUM MANAGEMENT LLC (150K shares), BANK OF MONTREAL /CAN/ (92.6K shares), GEODE CAPITAL MANAGEMENT, LLC (81.2K shares), Cerity Partners LLC (53.3K shares), BlackRock Inc. (41.5K shares), STATE STREET CORP (29.6K shares), and RENAISSANCE TECHNOLOGIES LLC (28.9K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.